Savara SVRA
NASDAQ SVRA
$5.37 +0.00 (+0.00%)
As of: Sep 4, 2026 · 3:59 PM EDT

Savara (SVRA) Change in Acquisitions & Divestments (2018 - 2026)

Savara (SVRA) posted quarterly Change in Acquisitions & Divestments of $13.1 million for Q1 2026, down 70.42% year-over-year from $44.4 million in Q1 2025, and up 108.84% quarter-over-quarter from -$148.5 million in Q4 2025.

Analysis

Savara (SVRA) Change in Acquisitions & Divestments (2018 - 2026) Analysis & Trends

Savara (SVRA) has reported Change in Acquisitions & Divestments for 9 consecutive years, with $13.1 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Change in Acquisitions & Divestments fell 70.42% year-over-year to $13.1 million; the TTM figure through Mar 2026 stood at -$27.0 million (down 116.07% YoY), while the FY2025 annual figure was $4.3 million, down 97.41% from the prior year.
  • Change in Acquisitions & Divestments rose to $13.1 million in Q1 2026 per SVRA's latest filing, from -$148.5 million in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $119.5 million in Q4 2022 and bottomed at -$148.5 million in Q4 2025.
  • Historically, Change in Acquisitions & Divestments has averaged $30.0 million across 5 years, with a median of $40.6 million in 2024.
  • Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments surged 300.3% — and 2025, when it slumped 397.34%.
  • Savara's Change in Acquisitions & Divestments stood at $119.5 million in 2022, then plunged by 62.01% to $45.4 million in 2023, then increased by 10.02% to $49.9 million in 2024, then plunged by 397.34% to -$148.5 million in 2025, then soared by 108.84% to $13.1 million in 2026.
  • Business Quant data shows SVRA's Change in Acquisitions & Divestments at $13.1 million in Q1 2026, -$148.5 million in Q4 2025, and $44.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Savara 1.36 Bn 1.36 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 52.20 Mn
Mar 31, 2026 25.70 Mn
Dec 31, 2025 29.40 Mn
Sep 30, 2025 44.40 Mn
Jun 30, 2025 64.00 Mn
Mar 31, 2025 44.40 Mn
Dec 31, 2024 49.95 Mn
Sep 30, 2024 40.55 Mn
Jun 30, 2024 33.00 Mn
Mar 31, 2024 41.50 Mn
Dec 31, 2023 45.40 Mn
Sep 30, 2023 38.00 Mn
Jun 30, 2023 30.00 Mn
Mar 31, 2023 24.00 Mn
Dec 31, 2022 14.20 Mn
Sep 30, 2022 33.00 Mn
Jun 30, 2022 25.20 Mn
Mar 31, 2022 58.39 Mn
Dec 31, 2021 15.60 Mn
Sep 30, 2021 34.59 Mn